Fundraise / allotmentNotableFiled on BSE ·

Natco Pharma Limited proposes Rights Issue of Equity Shares as of September 9, 2026

Natco Pharma Ltd · Pharmaceuticals & Biotechnology

What the filing says

  • The company filed a Draft Letter of Offer for a Rights Issue of Equity Shares with BSE and NSE on September 9, 2026.
  • All directors and chief financial officer certified compliance with relevant Companies Act, SEBI regulations, and that disclosures are true and correct.
  • The Rights Issue will comply with SEBI ICDR Regulations, involve opening a separate bank account for issue proceeds, and ensure listing and trading commencement within SEBI time limits.

Why it's rated notable: not yet binding (letter of intent, proposal or subject to approvals)

Original filing

Announcement under Regulation 30 (LODR)-Issue of Securities

Read the filing on BSE (PDF) →

Companies guiding to strong growth

Ranked by management's own guidance on revenue and margins — not by us.

Waaree Energies Ltd

Electrical Equipment

Revenue growth 40%+Margin up 2%+

Sign up free to see all 6 →

See full rankings

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

More from Natco Pharma Ltd

Other fundraise / allotment filings this fortnight

All fundraise / allotment filings →

Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.